Michelle Wang, PharmD, PhD

Assistant Professor
Department of Bioengineering and Therapeutic Sciences
1700 4th Street
San Francisco, CA 94158
United States

Links

UCSF Profiles

Biography

Michelle's research group is interested in developing AI-driven methods that integrate multi-modal, real-world data to innovate therapeutic strategies for diverse populations. Her research bridges medical informatics, pharmaceutical sciences, regulatory sciences, and clinical pharmacy, focusing on personalized therapeutic effects, precision drug discovery, and AI solutions to advance clinical care for cancers, inflammatory diseases, and cardiometabolic conditions.

Research keywords

  • real-world data
  • drug discovery and development
  • artificial intelligence
  • Medical Informatics
  • data-driven precision medicine
  • Protein-Tyrosine Kinases
  • Protein Kinase Inhibitors
  • Carcinoma, Non-Small-Cell Lung
  • Transfusion Reaction
  • Electronic Health Records
  • Diabetes Complications
  • Carcinoma, Renal Cell
  • Physicians
  • artificial intelligence
  • Bradycardia
  • Clinical Trials as Topic
  • Patient Acuity
  • Lung Neoplasms
  • Natural Language Processing
  • Blood Transfusion

Publications

Ayers AT, Ho CN, Kerr D, Cichosz SL, Mathioudakis N, Wang M, Najafi B, Moon SJ, Pandey A, Klonoff DC. Artificial Intelligence to Diagnose Complications of Diabetes. J Diabetes Sci Technol. 2025 Jan; 19(1):246-264.
Williams CYK, Zack T, Miao BY, Sushil M, Wang M, Kornblith AE, Butte AJ. Use of a Large Language Model to Assess Clinical Acuity of Adults in the Emergency Department. JAMA Netw Open. 2024 05 01; 7(5):e248895.
Miao BY, Sushil M, Xu A, Wang M, Arneson D, Berkley E, Subash M, Vashisht R, Rudrapatna V, Butte AJ. Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing. Lancet Digit Health. 2024 Mar; 6(3):e222-e229.
Silverstein J, Wright F, Wang M, Young A, Kim D, De Dios K, Brondfield S, Quandt Z. Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors. Oncologist. 2023 10 03; 28(10):e950-e959.
Wang M, Slatter S, Sussell J, Lin CW, Ogale S, Datta D, Butte AJ, Bazhenova L, Rudrapatna VA. ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study. Target Oncol. 2023 Jul; 18(4):571-583.
Wang M, Sushil M, Miao BY, Butte AJ. Bottom-up and top-down paradigms of artificial intelligence research approaches to healthcare data science using growing real-world big data. J Am Med Inform Assoc. 2023 06 20; 30(7):1323-1332.
Wang M, Goldgof GM, Patel A, Whitaker B, Belov A, Chan B, Phelps E, Rubin B, Anderson S, Butte AJ. Novel computational methods on electronic health record yields new estimates of transfusion-associated circulatory overload in populations enriched with high-risk patients. Transfusion. 2023 07; 63(7):1298-1309.
Miao BY, Arneson D, Wang M, Butte AJ. Open challenges in developing digital therapeutics in the United States. PLOS Digit Health. 2022 Jan; 1(1):e0000008.